Pharmaceutical Business Confidence Report Q1 2014

1
Pharmaceutical Business Confidence Report Q1 2014
One-Stop Shop for Business Information
2
Summary
Pharmaceutical Business Confidence Report Q1
2014 is a new report by Kable that analyzes
pharmaceutical industry executives views on the
global economy, expectations on customer
confidence, supplier prices, key business
concerns, and how executives future investments
are set to change in Q1 2014. This report also
gives you access to regional analysis of industry
outlook, industry and company growth prospects,
future opportunities, staff hiring, and sales
performance. Apart from providing access to the
opinions and strategies of global pharmaceutical
industry executives, it also examines their
actions surrounding business priorities, threats
and opportunities, and future investment areas
over the next six months.
3
Moreover, this report provides a comparative
analysis of survey results with Q4 2013 wherever
applicable. Introduction and Landscape Why was
the report written? his report is the result of
an extensive survey drawn from Kables exclusive
panel of leading global pharmaceutical industry
executives. The report analyzes current economic
conditions prevailing across the globe and their
impact on the pharmaceutical industry, and
forecasts company and industry growth prospects
over the next six months.
4
Furthermore, it provides information about the
impact of customer confidence, supplier prices,
and staff headcount likely to affect the
investment decisions of the industry over the
next six months. Additionally, this report tracks
the change in executives perceptions during the
last three months, by providing a comparative
analysis of survey results with the previous
quarter. What is the current market landscape
and what is changing?Overall, 74 and 60 of
global pharmaceutical industry executives are
optimistic about the future growth prospects of
both their company and the industry,
respectively, over the next six months.
5
Optimism towards company and industry growth
prospects has improved by eight and ten
percentage points, respectively, in Q1 2014,
compared to Q4 2013 results. What are the key
drivers behind recent market changes?Optimism
towards industry and company growth is driven by
the improving global economic conditions,
investments in emerging markets, and the
introduction of new products in the market. What
makes this report unique and essential to read?
6
Pharmaceutical Business Confidence Report Q1
2014 is a new report by Kable that analyzes the
industry sentiments globally on the latest
economic and customer issues and their impact
upon investment decisions and growth prospects
within the pharmaceutical industry. This report
also examines the executive opinion about the
current and future state of the economy and its
retrospective effect on the industry.
Furthermore, it analyzes the likely effect of
supplier price changes, sales performance, and
staff headcount within the industry over the next
six months. In addition, it provides an overview
of the key priorities, threats, and opportunities
for the global pharmaceutical industry over the
next six months.
7
Key Features and Benefits Project industry
trends and industry growth expectations in the
next six months, and understand business
confidence to make informed business
decisions. Readers will be provided with a clear
uncovering of key challenges and opportunities,
and identify the key priorities likely to affect
growth prospects of the industry. The report
clearly forecasts the change in supplier prices
for various products, which are likely to
influence the industrys growth prospects over
the next six months.
8
Key Market Issues According to pharmaceutical
industry respondents, the present economic
conditions in Africa and the Middle East are
deemed to be unfavourable. In the Q4 2013 survey,
similar opinions were recorded.New government
proposals/legislation, competition from new
entrants, state of global economy, and
performance of the Eurozone are the key concerns
among global pharmaceutical industry
executives.Survey respondents forecast that
supplier prices for raw materials will increase
at an average of 4.1, with those from
Asia-Pacific expecting the biggest rise.
9
Related Reports

• Estonia Pharmaceuticals and Healthcare Report
• Canada Pharmaceuticals and Healthcare Report
• Kazakhstan Pharmaceuticals and Healthcare Report
• Puerto Rico Pharmaceuticals and Healthcare Report
• Pharmaceutical Membrane Filtration Market by
  Technology, Application

10
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and benchmarks.

11
For More Information You Can Visit

• http//www.bharatbook.com/healthcare-market-resear
  ch-reports-437681/pharmaceutical-business-confiden
  ce-report-q1-2014.html

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email
info_at_bharatbook.com